Cg Oncology (CGON) traded down -1.33 % during a 24 hours period ending at 03:11 PM Central Europe on Monday 26th. One Cg Oncology stock can currently be bought for about USD 62.17 on popular exchanges. Current supply of Cg Oncology stocks is 88.6 mn. Cg Oncology has a current market capitalization of USD 5.5 bn and approximately USD 65.7 mn worth of Cg Oncology was traded on exchanges in the last 24 hours. Since last month end, Cg Oncology has traded -10.25 % down. Simple moving average of last 200 days is at USD 65.61. The highest price of past 52 weeks was recorded at USD 80.97 on 08/19/2026. 52 weeks low was at USD 35.8 on 11/11/2025.
Here is how related stocks have performed in the past 24 hours:
Hims & Hers Health (HIMS) traded down -4.87 % and now trades at USD 27.55. Current market capitalisation for Hims & Hers Health is USD 6.5 bn.
Lantheus (LNTH) traded down -0.3 % and now trades at USD 99.96. Lantheus has a market capitalisation of USD 6.5 bn. Lantheus has a current price to earnings ratio of 24.07.
Lyft (LYFT) traded down -2.81 % and now trades at USD 17.16. Lyft has a market capitalisation of USD 6.4 bn. Current price/earnings ratio for Lyft is 2.35.
United Bankshares (UBSI) traded up 0.43 % and now trades at USD 49.22. United Bankshares has a market capitalisation of USD 6.6 bn. United Bankshares has a current price to earnings ratio of 13.29.
Amdocs (DOX) traded down -1.31 % and now trades at USD 63.37. Current market capitalisation for Amdocs is USD 6.6 bn. Amdocs has a current price to earnings ratio of 14.9.
About Cg Oncology
CG Oncology, Inc. is a late-stage biopharmaceutical company based in Irvine, United States. The company specializes in developing and commercializing a potential bladder-sparing therapeutic for patients affected by bladder cancer. CG Oncology operates in the medical sector of the United States and can be accessed through its website at www.cgoncology.com . The company’s stock is traded on the Nasdaq stock exchange and is scheduled to go public on January 25, 2024.
